Marea Therapeutics
CA - South SFBiotechnology
Focus: Marea Therapeutics is a public biotech company focused on cardiometabolic disease treatments, headquartered in South San Francisco and founded in 2018. The company operates a lean, focused pipeline in metabolic diseases and specialty endocrinology.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
2 added, 1 removed. Backfill posture.
Should You Work at Marea Therapeutics?
AI assessmentSuitable for early-career scientists or specialists willing to accept pre-revenue risk in exchange for outsized impact and pipeline upside in a narrow therapeutic focus.
Why Work Here
- Early-stage public company with pipeline momentum: MAR001 in Phase 1/2 for hypertriglyceridemia and MAR002 entering Phase 1 data presentation stage (ENDO 2026)
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MAR002
AcromegalyClinical Trials (2)
NCT07641179A Study to Evaluate MAR002 for Acromegaly
Phase 2Help build intelligence for Marea Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.